Account
Insider Insights
22.02.2024
Nordic Pharmaceutical Forum develops new website t...

New website provides regular updates on NLF's work, addresses challenges, and showcases collaboratio...

Read more
Insider Insights
06.02.2024
Confidential rebates are raising concerns in Germa...

Proposed changes in Germany's pharma strategy suggest replacing publicly listed AMNOG rebates with c...

Read more
Insider Insights
30.01.2024
New MHRA procedure can accelerate patient access t...

The Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has implemented the Interna...

Read more
Articles
24.01.2024
What are the 5 Pricing & Market Access trends...

Our experts provide an overview of the five key trends that could shape the pricing and market acces...

Read more
Articles
13.12.2023
Reflecting on the Pricing & Market Access tre...

Back in January this year, we summarised the key trends our market access experts believed would dom...

Read more
Insider Insights
06.12.2023
New rebate percentages in the Statutory Scheme are...

The statutory scheme has been updated with new percentages for 2024-2026, and has received backlash ...

Read more
Insider Insights
04.12.2023
To improve Germany’s attractiveness, confidentia...

Germany’s Health minister has announced that publicly listed AMNOG rebates could be replaced by co...

Read more
Insider Insights
22.11.2023
AIFA reform set to move forward after receiving th...

AIFA reform is a landmark change which propels Italy towards expedited drug approvals and improved a...

Read more
Insider Insights
21.11.2023
Landmark deal reached on UK voluntary rebate schem...

Government, NHS, and Pharma Industry Unveil Successor to Voluntary Scheme for Branded Medicines Pric...

Read more
News
16.11.2023
ISPOR Europe 2023

We're thrilled to announce our participation at ISPOR Europe 2023 in Copenhagen this November. We'll...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.